Fresenius Medical Care AG (FMCQF) Non Operating Interest Expenses (2009 - 2026)

Fresenius Medical Care AG has reported Non Operating Interest Expenses for 18 years, with the latest figure at $113.4 million in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses rose 3.72% year-over-year to $113.4 million in Q2 2026; TTM through Jun 2026 was $446.7 million, a 4.67% increase from a year earlier, with the FY2025 full-year figure at $447.5 million, up 2.87% from the prior year.
• Non Operating Interest Expenses was $113.4 million for Q2 2026 at Fresenius Medical Care AG, up from $109.2 million in the prior quarter.
• The five-year high for Non Operating Interest Expenses was $123.9 million in Q3 2023, with the low at $90.0 million in Q2 2022.
• Average Non Operating Interest Expenses over 5 years is $107.6 million, with a median of $109.0 million recorded in 2026.
• The sharpest annual moves came in 2022 and 2023: Non Operating Interest Expenses retreated 15.23% in 2022, then soared 32.84% in 2023.
• Over 5 years, Non Operating Interest Expenses stood at $102.0 million in 2022, then climbed by 18.11% to $120.5 million in 2023, then declined by 10.44% to $107.9 million in 2024, then advanced by 6.78% to $115.2 million in 2025, then fell by 1.6% to $113.4 million in 2026.
• The last three Non Operating Interest Expenses figures came in at $113.4 million (Q2 2026), $109.2 million (Q1 2026), and $115.2 million (Q4 2025), per Business Quant data.